These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17488159)

  • 1. Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma.
    Bakshi NA; Finn WG; Schnitzer B; Valdez R; Ross CW
    Arch Pathol Lab Med; 2007 May; 131(5):742-7. PubMed ID: 17488159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of fascin expression in anaplastic large cell lymphoma and Hodgkin disease.
    Fan G; Kotylo P; Neiman RS; Braziel RM
    Am J Clin Pathol; 2003 Feb; 119(2):199-204. PubMed ID: 12579989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders.
    Kempf W; Levi E; Kamarashev J; Kutzner H; Pfeifer W; Petrogiannis-Haliotis T; Burg G; Kadin ME
    J Cutan Pathol; 2002 May; 29(5):295-300. PubMed ID: 12100631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.
    Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ
    Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma.
    Bhargava P; Pantanowitz L; Pinkus GS; Pinkus JL; Paessler ME; Roullet M; Gautam S; Bagg A; Kadin ME
    Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):16-23. PubMed ID: 19550297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.
    Slack GW; Ferry JA; Hasserjian RP; Sohani AR; Longtine JA; Harris NL; Zukerberg LR
    Leuk Lymphoma; 2009 Jun; 50(6):937-43. PubMed ID: 19455461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histologic, immunohistochemical, and genetic features of classical Hodgkin lymphoma and anaplastic large cell lymphoma with aberrant T-cell/B-cell antigen expression.
    Liang K; Wang J; Wang Y; Zhou Z; Ge S; Mei S; Li H; Jing X; Zhang C
    Hum Pathol; 2019 Feb; 84():309-320. PubMed ID: 30339972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form.
    ten Berge RL; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Oudejans JJ; Meijer JW; Willemze R; Hilgers J; Meijer CJ
    J Clin Pathol; 2001 Dec; 54(12):933-9. PubMed ID: 11729213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent expression of follicular dendritic cell markers in Hodgkin lymphoma and anaplastic large cell lymphoma.
    Kim SH; Choe JY; Jeon Y; Huh J; Jung HR; Choi YD; Kim HJ; Cha HJ; Park WS; Kim JE
    J Clin Pathol; 2013 Jul; 66(7):589-96. PubMed ID: 23454725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
    Moore EM; Swerdlow SH; Gibson SE
    Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic Cell Markers and PD-L1 are Expressed in Mediastinal Gray Zone Lymphoma.
    Pelland K; Mathews S; Kamath A; Cohen P; Hudnall SD; Cotta CV; Xu ML
    Appl Immunohistochem Mol Morphol; 2018; 26(10):e101-e106. PubMed ID: 29189264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases.
    Vassallo J; Lamant L; Brugieres L; Gaillard F; Campo E; Brousset P; Delsol G
    Am J Surg Pathol; 2006 Feb; 30(2):223-9. PubMed ID: 16434897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is fascin really a useful marker in distinguishing between classical Hodgkin's lymphoma and various types of non-Hodgkin's lymphomas in difficult cases?
    Idrees R; Ahmad Z; Qureshi A; Ahsan A; Pervez S
    J Clin Pathol; 2010 Jul; 63(7):571-4. PubMed ID: 20591908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma.
    Tamaru J; Tokuhira M; Nittsu N; Nakamura S; Ichinohasama R; Suzuki R; Mori H; Takagi T; Suzuki T; Itami J; Itoyama S; Mikata A
    Leuk Lymphoma; 2007 Jun; 48(6):1127-38. PubMed ID: 17577776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma.
    Salama ME; Rajan Mariappan M; Inamdar K; Tripp SR; Perkins SL
    Int J Surg Pathol; 2010 Apr; 18(2):121-8. PubMed ID: 19223373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
    Peh SC; Kim LH; Poppema S
    Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas.
    Xie W; Medeiros LJ; Li S; Yin CC; Khoury JD; Xu J
    Curr Hematol Malig Rep; 2020 Aug; 15(4):372-381. PubMed ID: 32394185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas.
    McQuaid DC; Katz SG; Xu ML
    Am J Clin Pathol; 2022 Aug; 158(2):173-176. PubMed ID: 35460405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules.
    Foss HD; Anagnostopoulos I; Araujo I; Assaf C; Demel G; Kummer JA; Hummel M; Stein H
    Blood; 1996 Nov; 88(10):4005-11. PubMed ID: 8916967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.